2021 Archives
You are viewing archived information from 2021
Measure Title: |
RELATING TO PRESCRIPTION DRUGS.
|
Report Title: |
Department of Commerce and Consumer Affairs; Prescription Drugs; Price Increases; Notification; Insurance Commissioner
|
Description: |
Requires drug manufacturers to notify prescription drug benefit plans and pharmacy benefit managers if a proposed increase in the wholesale price of certain drugs would result in a sixteen per cent or more price increase over a twoyear period. Requires the drug manufacturer to identify and report to the insurance commissioner information on certain drugs whose wholesale acquisition cost increases by a certain amount during a specified time frame.
|
Companion: |
HB17
|
Package: |
None
|
Current Referral: |
HTH, CPN
|
Introducer(s): |
BAKER, GABBARD, KEITH-AGARAN, KEOHOKALOLE, RHOADS, SAN BUENAVENTURA, Ihara, Kidani, Nishihara, Shimabukuro, Taniguchi
|
Act: |
|
Sort by Date | | Status Text |
2/10/2021 | S | The committee on HTH deferred the measure. |
2/5/2021 | S | The committee(s) on HTH has scheduled a public hearing on 02-10-21 1:00PM in conference room Via Videoconference. |
1/27/2021 | S | Referred to HTH, CPN. |
1/25/2021 | S | Passed First Reading. |
1/22/2021 | S | Introduced. |
S = Senate |
H = House |
D = Data Systems |
$ = Appropriation measure |
ConAm = Constitutional Amendment
Some of the above items require Adobe Acrobat Reader. Please visit
Adobe's download page
for detailed instructions.
SB605
No other committee reports available at this time.
You may search in our Document Directories if you believe this message is in error. The link is on the home page under Search.
HTH
2/10/21 1:00P
Via Videoconference